01.09.20|CTechThe company aims to conduct the first human trials of its cold therapy treatment at the beginning of 2021
07.01.20|Golan Hazani The Israel-based cancer treatment developer wants to raise $100 million according to a $400 million company valuation
29.05.19|Hagar RavetPi Therapeutics develops novel modulators of protein degradation for the treatment of cancer
07.11.17|Dror ReichThe companies signed an exclusive licensing agreement in Japan for VBL's anti-cancer drug